Samsung Pharm Capital Reinvestment Ratio
Samsung Pharm capital reinvestment ratio. Samsung Pharm (001360) has a Capital Reinvestment Ratio of 0.40x as of June 2022, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩638.30 Million). See 001360 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Samsung Pharm (2017–2017)
Capital reinvestment ratio of Samsung Pharm from 2017 to 2017. This chart tracks Samsung Pharm's Capital Reinvestment Ratio across 1 annual periods. See 001360 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Samsung Pharm Capital Reinvestment Ratio by Year (2017–2017)
Samsung Pharm capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see 001360 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 1.19x | ₩5.15 Billion | ₩6.11 Billion | — |